revision
-
Recon
Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
WARSAW, Ind., and ZURICH, Nov. 18, 2024 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the…
Read More » -
Recon
Medacta unveils the extended enhancements to its Hip Revision Platform
CASTEL SAN PIETRO, October 21, 2024—Medacta Group SA (‘Medacta,’ SIX:MOVE) is pleased to announce the further expansion of its comprehensive Hip…
Read More » -
Recon
HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery
Randomized Clinical Trial to Explore the Efficacy of Concentrated Bone Marrow Aspirate as an Addition to ACL Revision Surgery NEW…
Read More » -
Spine
New clinical study demonstrates Medacta’s MySpine accuracy in screw replacement during spine revision surgery
CASTEL SAN PIETRO, 20 March 2023 – Medacta Group SA (“Medacta”, SIX:MOVE), a Swiss company specializing in the design, production,…
Read More » -
Recon
Study aims to improve diagnosis of infections following shoulder surgery
UTSW researchers joined colleagues at 11 hospitals to examine infections after arthroplasty revisions. DALLAS – November 2, 2022 /OrthoSpineNews/– The…
Read More » -
Recon
HSS Study Could Help Surgeons Improve Mobility Outcomes After Revision Total Knee Arthroplasty
SAN DIEGO, Sept. 2, 2021 /PRNewswire/ — A new study by researchers at Hospital for Special Surgery (HSS) in New York City presented today at…
Read More » -
Recon
Fuse Medical, Inc. Announces FDA 510(k) Clearance of the Sterizo™ Tibial Revision Knee System and PS Plus Posterior Stabilized Tibial Insert
August 26, 2021 RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of…
Read More » -
Recon
Orthofix Announces US and European Full Market Launch of OSCAR PRO System for Removal of Cement During Complex Joint Revision Surgeries
May 17, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today…
Read More » -
Regulatory
Life Spine Announces FDA 510(k) Clearance for SI Joint Revision Offering and Additional Claims for the SImpact® Sacroiliac Joint Fixation System
September 22, 2020 HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the…
Read More »